Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay

R A Gniewek1, D P Stites, T M McHugh

  • 1Bio-Rad Laboratories, Hercules, California 94547, USA.

Insights

Enzyme immunoassay (ANA-EIA) for anti-nuclear antibodies shows similar sensitivity but improved specificity compared to immunofluorescence assay (ANA-IFA). This suggests ANA-EIA is a more accurate diagnostic tool for connective tissue diseases.

Area of Science:

  • Immunology
  • Clinical Chemistry
  • Autoimmunity

Background:

  • Anti-nuclear antibody (ANA) testing is crucial for diagnosing autoimmune and connective tissue diseases.
  • Immunofluorescence assay (ANA-IFA) and enzyme immunoassay (ANA-EIA) are common methods for ANA detection.
  • Comparative performance data between ANA-IFA and ANA-EIA in relation to patient diagnosis is essential for clinical practice.

Purpose of the Study:

  • To compare the diagnostic performance of ANA-IFA and ANA-EIA.
  • To evaluate sensitivity, specificity, and predictive values of both assays in a patient cohort.
  • To determine the optimal assay for ANA detection in clinical settings.

Main Methods:

  • A total of 467 patient serum samples were analyzed using both ANA-IFA (Kallestad; Sanofi) and ANA-EIA (RADIAS; Bio-Rad).
  • Patient data including age, sex, diagnosis, disease status, and medications were collected via chart review.
  • Reference ranges were established using 98 healthy blood donor samples.

Main Results:

  • ANA-EIA demonstrated higher specificity (60.2%) compared to ANA-IFA (48.0%).
  • Sensitivity was comparable between ANA-EIA (90.7%) and ANA-IFA (87.2%).
  • Positive predictive value was 35.8% for ANA-EIA and 29.1% for ANA-IFA, while negative predictive values were 96.4% and 93.9%, respectively.

Conclusions:

  • ANA-EIA offers equivalent sensitivity and superior specificity to ANA-IFA for anti-nuclear antibody testing.
  • The findings support the use of ANA-EIA as a potentially more accurate and reliable method for diagnosing connective tissue diseases.

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
The...
Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.